Arrowhead Pharmaceuticals Inc. buy B. Riley Financial, Inc.
Start price
30.07.26
/
50%
€74.86
Target price
30.07.27
€107.38
Performance (%)
-1.92%
Price
31.07.26
€73.42
Summary
This prediction is currently active. With a performance of -1.92%, the BUY prediction by B__Riley_Financial__ is trending in the wrong direction. This prediction currently runs until 30.07.27. The prediction end date can be changed by B__Riley_Financial__ at any time. B__Riley_Financial__ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Arrowhead Pharmaceuticals Inc. | -1.92% |
| iShares Core DAX® | 2.591% |
| iShares Nasdaq 100 | -0.915% |
| iShares Nikkei 225® | 0.145% |
| iShares S&P 500 | -0.367% |
Comments by B__Riley_Financial__ for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals (ARWR) had its price target raised by B. Riley Financial, Inc. from $101.00 to $123.00. They now have a "buy" rating on the stock.
Ratings data for ARWR provided by MarketBeat